PUBLISHED 2013

These recommendations suggest practices that a pharmaceutical entity could employ to identify and help minimize the risks associated with storing pharmaceutical products.

The points offered for consideration in this paper are presented in general, flexible terms and offer guidance to a company seeking to design a more secure storage facility. The processes described could help an organization analyze its own particular risks in addition to developing and implementing a suitable security strategy.